Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | +20.14% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | +17.28% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
- The Biotech Growth Trust Plc - Net Asset Value(s)
- The Biotech Growth Trust Plc - Monthly Fact Sheet as at 30 April 2024
- The Biotech Growth Trust Plc - Transaction in Own Shares
- The Biotech Growth Trust Plc - Compliance with Market Abuse Regulation
- The Biotech Growth Trust Plc - Total Voting Rights
- The Biotech Growth Trust Plc - Monthly Fact Sheet as at 31 March 2024
- The Biotech Growth Trust Plc - Director/PDMR Shareholding
- The Biotech Growth Trust Plc - Monthly Fact Sheet as at 29 February 2024
- The Biotech Growth Trust Plc - Director Declaration
- The Biotech Growth Trust Plc - Blocklisting - Interim Review
More ▼
Key statistics
As of last trade The Biotech Growth Trust PLC (BIOG:LSE) traded at 998.18, -4.75% below its 52-week high of 1,048.00, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 33.37m |
---|---|
Market cap | 333.72m GBP |
Total assets | 392.80m GBP |
Total expense ratio | 1.08% |
High | 999.00 |
Low | 999.00 |
Previous close | 990.00 |
Average volume | 46.54k |
---|---|
YTD Change | +11.65% |
Beta | 0.6391 |
Diluted NAV (est) | 1,070.94 |
Diluted NAV (last pub) | 1,079.38 |
Premium/Discount | -7.56% |
Net Gearing | +7.18% |
Data delayed at least 20 minutes, as of May 17 2024 09:58 BST.
More ▼